Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 17,191 | 16,716 | 16,226 | 13,571 | 14,896 |
| Operating Income | -17,191 | -16,716 | -16,226 | -13,571 | -14,896 |
| Other Income | 300 | 499 | 747 | 846 | 1,090 |
| Pre-tax Income | -16,891 | -16,217 | -15,479 | -12,725 | -13,806 |
| Income Tax | 31 | 28 | 27 | N/A | N/A |
| Net Income Continuous | -16,922 | -16,245 | -15,506 | -12,827 | -13,806 |
| Net Income | $-16,922 | $-16,245 | $-15,506 | $-12,827 | $-13,806 |
| EPS Basic Total Ops | -0.56 | -0.67 | -0.65 | 1.27 | -0.58 |
| EPS Basic Continuous Ops | -0.56 | -0.67 | -0.65 | -0.41 | -0.58 |
| EPS Diluted Total Ops | -0.56 | -0.67 | -0.65 | 1.27 | -0.58 |
| EPS Diluted Continuous Ops | -0.56 | -0.67 | -0.65 | -0.41 | -0.58 |
| EBITDA(a) | $-16,750 | $-16,349 | $-15,920 | $-13,267 | $-14,638 |